237 related articles for article (PubMed ID: 37924439)
1. Systemic Treatment for Brain Metastasis and Leptomeningeal Disease in Breast Cancer Patients.
Puri S; Chaudhry A; Bayable A; Ganesh A; Daher A; Gadi VK; Maraka S
Curr Oncol Rep; 2023 Dec; 25(12):1419-1430. PubMed ID: 37924439
[TBL] [Abstract][Full Text] [Related]
2. Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease.
Mills MN; King W; Soyano A; Pina Y; Czerniecki BJ; Forsyth PA; Soliman H; Han HS; Ahmed KA
J Neurooncol; 2022 Apr; 157(2):249-269. PubMed ID: 35244835
[TBL] [Abstract][Full Text] [Related]
3. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
[TBL] [Abstract][Full Text] [Related]
4. A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.
McKee MJ; Keith K; Deal AM; Garrett AL; Wheless AA; Green RL; Benbow JM; Dees EC; Carey LA; Ewend MG; Anders CK; Zagar TM
Oncologist; 2016 Jan; 21(1):16-20. PubMed ID: 26659221
[TBL] [Abstract][Full Text] [Related]
5. Systemic Therapy Approaches for Breast Cancer Brain and Leptomeningeal Metastases.
Dhakal A; Van Swearingen AED; O'Regan R; Anders CK
Curr Treat Options Oncol; 2022 Oct; 23(10):1457-1476. PubMed ID: 36136177
[TBL] [Abstract][Full Text] [Related]
6. Management of brain metastases in breast cancer: a review of current practices and emerging treatments.
Mills MN; Figura NB; Arrington JA; Yu HM; Etame AB; Vogelbaum MA; Soliman H; Czerniecki BJ; Forsyth PA; Han HS; Ahmed KA
Breast Cancer Res Treat; 2020 Apr; 180(2):279-300. PubMed ID: 32030570
[TBL] [Abstract][Full Text] [Related]
7. Optimal management of brain metastases from breast cancer. Issues and considerations.
Bartsch R; Berghoff AS; Preusser M
CNS Drugs; 2013 Feb; 27(2):121-34. PubMed ID: 23239265
[TBL] [Abstract][Full Text] [Related]
8. DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer.
Borm KJ; Behzadi ST; Hörner-Rieber J; Krug D; Baumann R; Corradini S; Duma MN; Dunst J; Fastner G; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Matuschek C; Piroth MD; Schmeel LC; Souchon R; Strnad V; Budach W; Combs SE;
Strahlenther Onkol; 2024 Apr; 200(4):259-275. PubMed ID: 38488902
[TBL] [Abstract][Full Text] [Related]
9. Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.
Shah N; Mohammad AS; Saralkar P; Sprowls SA; Vickers SD; John D; Tallman RM; Lucke-Wold BP; Jarrell KE; Pinti M; Nolan RL; Lockman PR
Pharmacol Res; 2018 Jun; 132():47-68. PubMed ID: 29604436
[TBL] [Abstract][Full Text] [Related]
10. Current challenges in the management of breast cancer brain metastases.
O'Sullivan CC; Davarpanah NN; Abraham J; Bates SE
Semin Oncol; 2017 Apr; 44(2):85-100. PubMed ID: 28923217
[TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
13. Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases.
Schlam I; Gatti-Mays ME
Oncologist; 2022 Jul; 27(7):538-547. PubMed ID: 35598254
[TBL] [Abstract][Full Text] [Related]
14. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK
Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy for leptomeningeal disease in breast cancer.
Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
[TBL] [Abstract][Full Text] [Related]
16. Current indications and future perspectives for antibody-drug conjugates in brain metastases of breast cancer.
Epaillard N; Bassil J; Pistilli B
Cancer Treat Rev; 2023 Sep; 119():102597. PubMed ID: 37454577
[TBL] [Abstract][Full Text] [Related]
17. Targeting HER2+ Breast Cancer Brain Metastases: A Review of Brain-Directed HER2-Directed Therapies.
Chiec L; Kumthekar P
CNS Drugs; 2022 Feb; 36(2):167-179. PubMed ID: 35075602
[TBL] [Abstract][Full Text] [Related]
18. [A retrospective analysis of clinic-pathological characteristics and prognostic factor for 137 cases of breast cancer brain metastasis].
Gao YC; Liu H; Lu S; Zhuang XR; Wang YX; Wang T; Wu YY; Chen MX
Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):30-4. PubMed ID: 23578424
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of patupilone in patients with brain metastases from breast cancer.
Peereboom DM; Murphy C; Ahluwalia MS; Conlin A; Eichler A; Van Poznak C; Baar J; Elson P; Seidman AD
Neuro Oncol; 2014 Apr; 16(4):579-83. PubMed ID: 24470546
[TBL] [Abstract][Full Text] [Related]
20. Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis.
Brown DA; Lu VM; Himes BT; Burns TC; Quiñones-Hinojosa A; Chaichana KL; Parney IF
Clin Exp Metastasis; 2020 Apr; 37(2):341-352. PubMed ID: 31950392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]